Myrto Ischyropoulou

Max Planck Institute of Experimental Medicine

ORCID: 0000-0003-2023-1351

Publishes on Radiopharmaceutical Chemistry and Applications, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography. 26 papers and 89 citations.

PubIndex Score31Top 69% · early-careerHow it's scored

26Publications

89Total Citations

First publication: 2018

Radiopharmaceutical Chemistry and Applications Crystallization and Solubility Studies X-ray Diffraction in Crystallography Peptidase Inhibition and Analysis Nanoparticle-Based Drug Delivery

Top publicationsby citations

High‐Load Gemcitabine Inorganic–Organic Hybrid Nanoparticles as an Image‐Guided Tumor‐Selective Drug‐Delivery System to Treat Pancreatic Cancer

Myrto Ischyropoulou, Frauke Alves, Kristina Sabljo et al.|Advanced Materials|2023

Cited by 35

Dicarbonyl cis-[M(CO)2(N,O)(C)(P)] (M = Re, 99mTc) Complexes with a New [2 + 1 + 1] Donor Atom Combination

Charalampos Triantis, Minas Papadopoulos, Antonio Shegani et al.|Inorganic Chemistry|2018

Cited by 24

Synthesis and evaluation of new mixed “2 + 1” Re, 99mTc and 186Re tricarbonyl dithiocarbamate complexes with different monodentate ligands

Antonio Shegani, Ioannis Pirmettis, Myrto Ischyropoulou et al.|Bioorganic & Medicinal Chemistry|2021

Cited by 15

High-load nanoparticles with a chemotherapeutic SN-38/FdUMP drug cocktail

Kristina Sabljo, Claus Feldmann, Myrto Ischyropoulou et al.|Nanoscale|2024

Cited by 5

Synthesis and Characterization of Novel [2 + 1] Tricarbonyl Rhenium Complexes with the Hydrophilic Phosphine Ligands PTA and CAP

Ioanna Roupa, Aristeidis Chiotellis, Charalampos Flampouraris et al.|Bioinorganic Chemistry and Applications|2022

Cited by 5